Back to Journals » OncoTargets and Therapy » Volume 12

CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Total article views   HTML views PDF downloads Totals
8,111 Dovepress* 6,298+ 1,353 7,651
PubMed Central* 1,813 381 2,194
Totals 8,111 1,734 9,845
*Since 28 May 2019
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar